Skip to main content

J&J Settles Three Asbestos-in-Talc Cases; Wins Another in NJ

J&J Settles Three Asbestos-in-Talc Cases; Wins Another in NJ

J&J Settles Three Asbestos-in-Talc Cases; Wins Another in NJ

Introduction

On Wednesday, March 27, in three separate trials held in Oklahoma, Los Angeles and New York, J&J confidentially settled three women's lawsuits which blamed asbestos-in-talc for their mesothelioma.

One of the plaintiffs was a 77-year-old woman who was diagnosed with peritoneal mesothelioma in 2017. Her attorneys said at trial that she used J&J's talc products for 50 years, which was the reason for her cancer.J&J confirmed the settlement in the Los Angeles trial involving claims filed by the 36-year-old plaintiff who developed pleural mesothelioma due to asbestos exposure from J&J's talcum powder. The third settlement involved claims filed by a 41-year-old woman who stated in her New York suit that she developed peritoneal mesothelioma due to the use of J&J's talcum powder for feminine hygiene purposes. J&J failed in an attempt to stop a plaintiff's expert from testifying that he detected asbestos and talc in the third plaintiff's ovarian and fallopian tissue. The trial was slated to begin on April 9 in Manhattan state court.

On the same day, Middlesex County Superior Court in New Brunswick ruled in favor of J&J in a lawsuit filed by a plaintiff, which linked asbestos presence to the man's mesothelioma. In a unanimous decision, the jury found that J&J's talc was free from asbestos and was not the reason for the plaintiff's cancer. One of his attorneys, Monica Cooper, told, they were quite disappointed with the jury verdict, particularly because there was immense scientific and documentary evidence to support the allegations against the company.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!